Biotech Medical Technologies
CMS proposed rule potential and potential legislation that includes provisions that would alter payment policies under Medicare Part B for drugs and biologics.
Issues dealing with value-based contracts.
Issues pertaining to Medicare Part D. Issues dealing with newborn screening.
Issues dealing with Alzheimer's treatments.
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THORN RUN PARTNERS
100 M Street, SE, Suite 750, Washington, DC, 20003, US
BEAU SCHUYLER (Legislative Director - Cong. Tanner, Legislative Director - Cong. McIntyre) BEAU SCHUYLER (Legislative Director - Cong. Tanner, Legislative Director - Cong, McIntyre)
Legislative Director - Cong. Tanner, Legislative Director - Cong. McIntyre Legislative Director - Cong. Tanner, Legislative Director - Cong, McIntyre